Patents for A61P 35 - Antineoplastic agents (221,099)
07/2006
07/12/2006CN1800184A Synthesis of temozolomide and analogs
07/12/2006CN1799630A Chitosan-immune RNA composite formulation and preparation method thereof
07/12/2006CN1799628A Mixed heat shock protein/peptide sarcoma vaccine and its preparation method
07/12/2006CN1799625A Preparation of officinal interleukin
07/12/2006CN1799624A chromatin peptide for blocking human HIF-1 alpha gene and regulating network downstream related gene
07/12/2006CN1799585A Intravenous administered formulation of spreading hedyotis herb and its preparation method
07/12/2006CN1799562A Antrodia camphorata mycelium fermented extract and application thereof
07/12/2006CN1799560A Liver cancer resistant Antrodia camphorata and preparation method thererof
07/12/2006CN1799554A Mannosan peptide injection and preparation method thereof
07/12/2006CN1799548A Soybean isoflavone phospholipid composition and preparation method thereof
07/12/2006CN1799546A Sodium folinate injection and preparation method thereof
07/12/2006CN1799536A Bexarotene gel and its preparation method
07/12/2006CN1263864C Recombinant adenoviral vector and methods of use
07/12/2006CN1263853C Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use
07/12/2006CN1263852C Extracellular matrix signalling molecules
07/12/2006CN1263768C New taraxerol derivative and its preparation and use
07/12/2006CN1263764C Platinum complex having anticancer activity
07/12/2006CN1263762C Desugar and deaminosugar FR-008 derived polyketone antibiotics
07/12/2006CN1263761C Process for isolation and purification of epothilones
07/12/2006CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives
07/12/2006CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors
07/12/2006CN1263751C Novel compounds
07/12/2006CN1263745C Aryl fused azapolycyclic compounds
07/12/2006CN1263743C Therapeutic morpholino-substituted compounds
07/12/2006CN1263733C Substituted phenyl derivatives, their preparation and use
07/12/2006CN1263730C Esters of L-carnitine or alkanoyl L-carnitines used as cation lipid for intracellular release pharmacological activity compound
07/12/2006CN1263507C APRIL receptor (BCMA) and uses thereof
07/12/2006CN1263499C Chinese medicine for treating cancer
07/12/2006CN1263466C Transfusing agent of active carbon and its preparation and application in preparing cancer-treating medicine
07/11/2006US7074930 Amine salts of an integrin receptor antagonist
07/11/2006US7074924 Compounds as cancer inhibitors in mixtures with other compounds such as methotrextrate
07/11/2006US7074921 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds
07/11/2006US7074909 Prevent, therapy of disease; isolated nucleic acid which codes antibody; binding to human antigen
07/11/2006US7074901 Nucleotide sequences coding polypeptides for use in the tumor/cancer therapy
07/11/2006US7074896 Gene expression of nucleic acid in prokaryotic cells; homogeneity, purity; immobilization; separation of antibodies by chromatography
07/11/2006US7074835 Anticancer agents
07/11/2006US7074829 Antiestrogens, process for their production and their pharmaceutical use
07/11/2006US7074821 Taxoids, their preparation and pharmaceutical composition containing them
07/11/2006US7074819 Benzopyran or thiobenzopyran derivatives
07/11/2006US7074814 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antiarthritic agents ; psoriasis
07/11/2006US7074807 Compositions and methods for inducing cell death
07/11/2006US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders
07/11/2006US7074802 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074800 Quinazoline derivatives as angiogenesis inhibitors
07/11/2006US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
07/11/2006US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
07/11/2006US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides
07/11/2006US7074789 Kinase inhibitors
07/11/2006US7074782 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor
07/11/2006US7074780 Substituted phenylcyclohexanecarboxamides and their use
07/11/2006US7074769 Antisense oligonucleotide or analog thereof comprising 10 or more contiguous bases or base analogs; for treating cancer
07/11/2006US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents
07/11/2006US7074620 Controlling protein levels in eucaryotic organisms
07/11/2006US7074613 Monoclonal antibody directed against cells of human renal cell carcinoma
07/11/2006US7074575 Anticancer activity of IL- 19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of ovarian cancer cells for ovarian
07/11/2006US7074574 Method of detecting growth differentiation factor-7 (GDF-7) using GDF-7 antibodies
07/11/2006US7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof
07/11/2006US7074438 Compositions for oral delivery of nutrients and pharmaceuticals
07/11/2006US7074427 Comprises a shell with a gas enclosed in the internal space thereof as well as a substance capable of generating active oxygen species upon irradiation of the shell with an ultrasound as retained or contained in shell; therapy
07/11/2006US7074408 Use of integrin antagonists to inhibit angiogenesis
07/11/2006US7074406 Treating allergic diseases with humanized anti-CD40L antibody
07/11/2006US7074405 antibody binds target tissue and conjugate carrying epitope (haptens)
07/11/2006US7074403 Immunotherapy of autoimmune disorders using antibodies which target B-cells
07/11/2006US7074400 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
07/11/2006US7074389 For therapy and prophylaxis, side effect reduction
07/11/2006CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors
07/11/2006CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them
07/11/2006CA2367306C New cycloheptene compounds, their preparation process and the pharmaceutical compounds containing them
07/11/2006CA2325779C New derivatives of 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbzole and 12,13 (pyranosyl)-furo[3,4-c]indol[2,3-a]carbazole, their preparation process and the pharmaceutical compositions therein
07/11/2006CA2319201C Celecoxib compositions
07/11/2006CA2293793C Rapamycin formulations for oral administration
07/11/2006CA2280100C Alkynyl-substituted camptothecins and process for their preparation
07/11/2006CA2246783C Mcbi analogs of cc-1065 and the duocarmycins
07/11/2006CA2231750C Hydrolysis-promoting taxane hydrophobic derivatives
07/11/2006CA2176463C Hu-b1.219, a novel human hematopoietin receptor
07/11/2006CA2158609C 5 .alpha.-reductase inhibitors
07/06/2006WO2006071983A2 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
07/06/2006WO2006071819A1 [1h-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
07/06/2006WO2006071644A1 Selective inhibitors of erk protein kinases and uses therof
07/06/2006WO2006071079A1 Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof
07/06/2006WO2006071035A1 Novel ([1,3]thiazolo[5,4-b]pyridin-2-yl)-2-carboxamide derivatives
07/06/2006WO2006070943A1 Condensed imidazole compound and use thereof
07/06/2006WO2006070927A1 Pyrimidinylisoxazol derivative
07/06/2006WO2006070891A1 Novel strain conferring anti-disease properties to host and bacterial cell composition
07/06/2006WO2006070874A1 Hypoxic response promoter
07/06/2006WO2006070804A1 Method of inhibiting telomerase activity and inhibitor
07/06/2006WO2006070348A1 PHARMACEUTICAL COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH NF-κB ACTIVITY
07/06/2006WO2006070202A1 Pyrazole derivatives having kinase modulating activity
07/06/2006WO2006070198A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
07/06/2006WO2006070195A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/06/2006WO2006070192A1 Thiazole and isothiazole derivatives that modulate the acivity of cdk, gsk and aurora kynases
07/06/2006WO2006069740A1 2, 5 and 2, 6-disubstituted benzazole analogues useful as protein kinase inhibitors
07/06/2006WO2006069533A1 Desmosdumotins, their manufactures and use as antitumor and anti-aids agent
07/06/2006WO2006069525A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
07/06/2006WO2006069512A1 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them
07/06/2006WO2006069449A1 Chemokine receptor-independent immunomodulatory and anti-proliferative activity
07/06/2006WO2006069441A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
07/06/2006WO2006057900A3 17,20(z)-dehydro vitamin d analogs and their uses
07/06/2006WO2006057899A3 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses